Skip to main content

Advertisement

Log in

Type 2 diabetes mellitus and prognosis in early stage breast cancer women

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

It has been suggested that type 2 diabetes mellitus may affect breast cancer prognosis, possibly due to increased diabetes-related comorbidity, or direct effects of insulin resistance and/or hyperinsulinemia. The aim of this study was to determine the impact of diabetes on disease-free survival (DFS) following mastectomy for breast cancer patients. The cases included in this retrospective study were selected from breast cancer women who had undergone mastectomy and completed adjuvant chemotherapy from 1998 to 2010. Patients were classified into two groups: diabetic and non-diabetic. Patients’ age, sex, menopausal status, body mass index (BMI), histopathological features, tumor size, lymph node involvement, hormone receptor and HER2-neu status, and treatment types were recorded. There were 483 breast cancer patients included in the study. Postmenopausal patients’ rate (53.7% vs. 36.8%, P = 0.016) and mean BMI levels were statistically higher (32.2 vs. 27.9, P = 0.007) in diabetic patients. There was no statistical difference for histological subgroup, grade, ER and PR positivity, HER2-neu overexpression rate, and tumor size between the diabetic and non-diabetic group. Lymph node involvements were statistically higher in diabetic patients compared with non-diabetic patients (P = 0.013). Median disease-free survival is 81 months (95% CI, 61.6–100.4) in non-diabetic patients and 36 months (95% CI, 13.6–58.4) in diabetic patients (P < 0.001). The odds ratio of recurrence was significantly increased in those with HER2-neu overexpression and lymph node involvement and decreased with PR-positive tumors. Our results suggest that diabetes is an independent prognostic factor for breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

  2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.

    Article  PubMed  Google Scholar 

  3. The DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2003;26:61–9.

    Article  Google Scholar 

  4. Papa V, Costantino A, Belfiore A. Insulin receptor what role in breast cancer? Trends Endocrinol Metab. 1997;8(8):306–12.

    Article  PubMed  CAS  Google Scholar 

  5. Van der Burg B, Rutteman GR, Blankenstein MA, de Laat SW, van Zoelen EJ. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol. 1988;134:101–8.

    Article  PubMed  Google Scholar 

  6. Belfiore A, Frittitta L, Costantino A, Frasca F, Pandini G, Sciacca L, et al. Insulin receptors in breast cancer. Ann NY Acad Sci. 1996;784:173–88.

    Article  PubMed  CAS  Google Scholar 

  7. Mathieu MC, Clark GM, Allred DC, Goldfine ID, Vigneri R. Insulin receptor expression and clinical outcome in node-negative breast cancer. Proc Assoc Am Physicians. 1997;109:565–71.

    PubMed  CAS  Google Scholar 

  8. Papa V, Belfiore A. Insulin receptors in breast cancer: biological and clinical role. J Endocrinol Invest. 1996;19:324–33.

    PubMed  CAS  Google Scholar 

  9. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300:2754–64.

    Article  PubMed  CAS  Google Scholar 

  10. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121:856–62.

    Article  PubMed  CAS  Google Scholar 

  11. Peairs KS, Barone BB, Snyder CF, Yeh HC, Stein KB, Rl Derr, et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol. 2011;29(1):40–6.

    Article  PubMed  Google Scholar 

  12. Srokowski TP, Fang S, Hortobagyi GN, Giordano SH. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol. 2009;27:2170–6.

    Article  PubMed  Google Scholar 

  13. Fleming ST, Rastogi A, Dmitrienko A, Jhonson KD. A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care. 1999;37:601–14.

    Article  PubMed  CAS  Google Scholar 

  14. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285:885–92.

    Article  PubMed  CAS  Google Scholar 

  15. Van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer. 2007;120:1986–92.

    Article  PubMed  Google Scholar 

  16. Fleming ST, Pursley HG, Newman B, Pavlov D, Chen K. Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care. 2005;43:132–40.

    Article  PubMed  Google Scholar 

  17. Unterburger P, Sinop A, Noder W, Berger MR, Fink M, Edler L, et al. Diabetes mellitus and breast cancer. A retrospective follow-up study. Onkologie. 1990;13(1):17–20.

    Article  PubMed  CAS  Google Scholar 

  18. Li CI, Daling JR, Tang MT, Malone KE. Relationship between diabetes and risk of second primary contralateral breast cancer. Breast Cancer Res Treat. 2011;125(2):545–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Muhammet Ali Kaplan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaplan, M.A., Pekkolay, Z., Kucukoner, M. et al. Type 2 diabetes mellitus and prognosis in early stage breast cancer women. Med Oncol 29, 1576–1580 (2012). https://doi.org/10.1007/s12032-011-0109-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-011-0109-4

Keywords

Navigation